leadf
logo-loader
NASDAQ:AKR

Akers Biosciences, Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$907.5 m
Price
10.56 USD
Change
0.57%
52 weeks high
29.49
52 weeks low
9.64

In brief

Akers Biosciences, Inc. (aka Akers Bio) was founded in 1989, with the objective of developing proprietary, in vitro diagnostic technologies that accelerate the rate at which clinicians, and in some cases consumers, can obtain health information. The tests and sample preparation devices that emerge from our rapid technology platforms are designed to provide the same level of accuracy as traditional laboratory testing methods, but at a fraction of the cost and turn-around time.